Last reviewed · How we verify

Single FT1050 treated UCB unit

Fate Therapeutics · Phase 1 active Biologic Quality 0/100

At a glance

Generic nameSingle FT1050 treated UCB unit
SponsorFate Therapeutics
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results